Journal of cardiothoracic and vascular anesthesia · 2003
Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass.
Клиническое исследованиеСравнительное исследованиеСтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Caimmi Philippe-Primo, Pagani Lorenzo, Micalizzi Ezio, Fiume Cosimo, Guani Simona, Bernardi Massimo, Parodi Fillipo, Cordero Gualtiero, Fregonara Maura, Kapetanakis Emmanouil, Panella Massinniano, Degasperis Carlo
Аннотация
OBJECTIVE: To evaluate the possible protective effects of fenoldopam on renal function in patients undergoing cardiopulmonary bypass.
DESIGN: Prospective, randomized trial.
SETTING: University teaching hospital.
PARTICIPANTS: One hundred sixty consecutive patients with serum creatinine >1.5 mg/dL who underwent uncomplicated moderate hypothermic cardiopulmonary bypass for cardiac surgery.
INTERVENTIONS: A random group of 80 patients was managed conventionally (group A), whereas another random group of 80 patients received continuous intravenous administration of low-dose fenoldopam (0.1-0.3 microg/kg/min) during cardiopulmonary bypass and in the early postoperative period (group B).
MEASUREMENTS AND MAIN RESULTS: An improvement of postoperative renal parameters were observed only in group B: preoperative serum creatinine 1.82 +/- 0.2 versus 1.43 +/- 0.73 postoperatively (p < 0.001), preoperative creatinine clearance 51.34 +/- 22.26 versus 67.14 +/- 18.55 postoperatively (p < 0.001).
CONCLUSIONS: In this study, fenoldopam was an effective agent in the prevention of renal dysfunction after cardiopulmonary bypass.
DESIGN: Prospective, randomized trial.
SETTING: University teaching hospital.
PARTICIPANTS: One hundred sixty consecutive patients with serum creatinine >1.5 mg/dL who underwent uncomplicated moderate hypothermic cardiopulmonary bypass for cardiac surgery.
INTERVENTIONS: A random group of 80 patients was managed conventionally (group A), whereas another random group of 80 patients received continuous intravenous administration of low-dose fenoldopam (0.1-0.3 microg/kg/min) during cardiopulmonary bypass and in the early postoperative period (group B).
MEASUREMENTS AND MAIN RESULTS: An improvement of postoperative renal parameters were observed only in group B: preoperative serum creatinine 1.82 +/- 0.2 versus 1.43 +/- 0.73 postoperatively (p < 0.001), preoperative creatinine clearance 51.34 +/- 22.26 versus 67.14 +/- 18.55 postoperatively (p < 0.001).
CONCLUSIONS: In this study, fenoldopam was an effective agent in the prevention of renal dysfunction after cardiopulmonary bypass.